Joint Active Systems shares study results
Elizabeth Murphy discusses JAS SPS elbow device study. 90% of participants recovered functional range of motion without surgery.
See the latest news and media coverage for JAS. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of orthopedic rehabilitation devices
jointactivesystems.comLast updated
In short: JAS promoted clinical study results showing a 90% success rate in patient mobility recovery and reaffirmed its healthcare compliance status.
Elizabeth Murphy discusses JAS SPS elbow device study. 90% of participants recovered functional range of motion without surgery.
These studies demonstrate proven outcomes. Full list available.
These studies demonstrate proven outcomes. Full list available.
Their ten-year study surveyed 6000 patients.
Living with joint pain? A top rheumatologist explains the everyday habits, from poor sleep to...
Anaconda expands its brace line with a shoulder support built for athletes in strength training, fitness, and contact sports who need joint stability during active...
Whole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss managementSAN FRANCISCO, CA / ACCESS Newswire / March 16, 2026 ...
On February 1, North Carolina Attorney General Josh Stein announced that his Medicaid Investigations Division reached a $500,000 settlement with Joint Active Systems, Inc. (JAS...
Track JAS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to JAS and other trending companies.